Michael Davenport, PhD, Head, Pharmacokinetics, Bioanalytical and Biostatistics for OrphoMed, has over 25 years of experience leading clinical, preclinical, research and development functions in the biopharmaceutical industry. He also has extensive experience in the pharmacokinetic aspects of drug development. Before joining OrphoMed in 2017, he founded AccuVanceKinetics, a sole proprietor LLC company that offers strategic drug development and of early stage programs from preIND through Phase 2. Previously, Dr. Davenport was the Executive Director of Clinical Pharmacology and Biostatistics at Furiex Pharmaceuticals, where he was responsible for clinical pharmacology, biostatistics, data management, bioanalytical, and central laboratories. Previously, he worked at Pharmaceutical Product Development (PPD), a contract research organization. At PPD, he served as Senior Director of Clinical Pharmacology and created development strategies and provided pharmacokinetic support to clients. He holds a BS in Mathematics and a Master’s degree in Statistics from the University of the Arkansas and a doctorate in biostatistics from the Virginia Commonwealth University.Michael Davenport, PhD, Head, Pharmacokinetics, Bioanalytical and Biostatistics for OrphoMed, has over 25 years of experience leading clinical, preclinical, research and development functions in the biopharmaceutical industry. He also has extensive experience in the pharmacokinetic aspects of drug development. Before joining OrphoMed in 2017, he founded AccuVanceKinetics, a sole proprietor LLC company that offers strategic drug development and of early stage programs from preIND through Phase 2. Previously, Dr. Davenport was the Executive Director of Clinical Pharmacology and Biostatistics at Furiex Pharmaceuticals, where he was responsible for clinical pharmacology, biostatistics, data management, bioanalytical, and central laboratories. Previously, he worked at Pharmaceutical Product Development (PPD), a contract research organization. At PPD, he served as Senior Director of Clinical Pharmacology and created development strategies and provided pharmacokinetic support to clients. He holds a BS in Mathematics and a Master’s degree in Statistics from the University of the Arkansas and a doctorate in biostatistics from the Virginia Commonwealth University.

Mathematics